References
- Harrison L C, Campbell I L, Colman P. G., et al. Type 1 diabetes: immunopathology and immunotherapy. Adv. Endocrinol. Metab 1990; 1: 35–94
- Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol 1992; 51: 285–322
- Shimada A, Charlton B, Taylor-Edwards C, Fathman C G. Beta-cell destruction may be a late consequence of the autoimmune process in non-obese diabetic mice. Diabetes 1996; 45: 1063–7
- Signore A, Pozzilli P, Gale E AM, Andreani D, Beverley P CL. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 1989; 32: 282–289
- Anderson J T, Cornelius J G, Jarpe A J, Winter W E, Peck A B. Insulin-dependent diabetes in the NOD mouse model. II. Beta-cell destruction in autoimmune diabetes is a Thl and not aTh2 mediated event. Autoimmunity 1993; 15: 113–122
- Signore A, Procaccini E, Toscano A M, Ferretti E, Williams A JK, Beales P E, Cugini P, Pozzilli P. Histological study of pancreatic beta cell loss in relation to the insulitis process in the non-obese diabetic mouse. Histochemistry 1994; 101: 263–269
- Bowman M A, Leiter E H, Atkinson M A. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. Immunology Today 1994; 15: 115–120
- Schmidli R, Colman P G, Bonifacio E. Disease sensitivity and specificity of fifty-two assays for glutamic acid decarboxylase antibodies: the second international GADAb workshop. Diabetes 1995; 44: 636–640
- Hagopian W A, Sanjeevi C B, Kockum I, Landin-Olsson M, Karlsen A E, Sundkvist G, Dahlquist G, Palmer J, Lernmark A. Glutamate decarboxylase, insulin and islet cell antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J. Clin. Invest 1995; 95: 1505–11
- Endl J, Otto H, Jung G, Dreisbusch B, Donie F, Stahl P, Elbracht R, Schmitz G, Meinl E, Hummel M, Ziegler A, Wank R, Schendel D. Identification of naturally processed T cell epitopes from GAD presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest 1999; 99: 2405–15
- Muto Y, Kure S, Sakata T, Masuda T, Shinka T, Matsubara Y, Satoh J, Narisawa K. Skin test for detection of cellular autoimmunity in IDDM: a study in NOD mouse. Diabetologia 1997; 40(Suppl. 1)A89, 346
- Her Majesty's Stationary Office, London 1986, Animals (Scientific Procedures) Act
- N.I.H. Principles of laboratory animal care. 1985, Publication no. 83-25, revised
- Mansfield K J, Beales P E, Williams A JK, Pozzilli P. The breeding, housing and life-maintenance of the non-obese diabetic mouse. Animal Technology 1992; 43: 29–37
- Pozzilli P, Signore A, Williams A JK, Beales P E. NOD mouse colonies around the world - recent facts and figures. Immunology Today 1993; 14: 193–196
- Kaufman D L, Clare-Salzler M, Tian J, Forsthuber T, Ting G SP, Robinson P, Atkinson M A, Sercarz E E, Tobin A J, Leh-Mann P. V. Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366: 69–71
- Tian J, Clare-Salzler M, Herschenfeld A, Middleton B, Newman D, Mueller R, Arita S, Evans C, Atkinson M A, Mullen Y, Sarvetnick N, Tobin A J, Lehmann P V, Kaufman D L. Modulating autoimmune responses to GAD inhibits disease progression and prolongs graft survival in diabetes-prone mice. Nature Medicine 1996; 2: 1348–53